This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Widschwendter, M. Articles by Ehrlich, M. Search for Related Content PubMed PubMed Citation Articles by Widschwendter, M. Articles by Ehrlich, M.

DNA Hypomethylation and Ovarian Cancer Biology

Departments of ¹ Obstetrics and Gynecology and ² Biostatistics and Documentation, Medical University Innsbruck, Innsbruck, Austria; ³ Tulane Cancer Center, Human Genetics Program, and Department of Biochemistry, Tulane Medical School, New Orleans, Louisiana; and Departments of ⁴ Surgery, Biochemistry, and Molecular Biology, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California

Hypomethylation of some portions of the genome and hypermethylation of others are very frequent in human cancer. The hypomethylation often involves satellite 2 (Sat2) DNA in the juxtacentromeric (centromere-adjacent) region of chromosome 1. In this study, we analyzed methylation in centromeric and juxtacentromeric satellite DNA in 115 ovarian cancers, 26 non-neoplastic ovarian specimens, and various normal somatic tissue standards. We found that hypomethylation of both types of satellite DNA in ovarian samples increased significantly from non-neoplastic toward cancer tissue. Furthermore, strong hypomethylation was significantly more prevalent in tumors of advanced stage or high grade. Importantly, extensive hypomethylation of Sat2 DNA in chromosome 1 was a highly significant marker of poor prognosis (relative risk for relapse, 4.1, and death, 9.4) and more informative than tumor grade or stage. Also, comparing methylation of satellite DNA and 15 5' gene regions, which are often hypermethylated in cancer or implicated in ovarian carcinogenesis, we generally found no positive or negative association between methylation changes in satellite DNA and in the gene regions. However, hypermethylation at two loci, CDH13 (at 16q24) and RNR1 (at 13p12), was correlated strongly with lower levels of Sat2 hypomethylation. The CDH13/Sat2 epigenetic correlation was seen also in breast cancers. We conclude that satellite DNA hypomethylation is an important issue in ovarian carcinogenesis as demonstrated by: (a) an increase from non-neoplastic tissue toward ovarian cancer; (b) an increase within the ovarian cancer group toward advanced grade and stage; and (c) the finding that strong hypomethylation was an independent marker of poor prognosis.

This article has been cited by other articles:

				A. Woloszynska-Read, P. Mhawech-Fauceglia, J. Yu, K. Odunsi, and A. R. Karpf Intertumor and Intratumor NY-ESO-1 Expression Heterogeneity Is Associated with Promoter-Specific and Global DNA Methylation Status in Ovarian Cancer Clin. Cancer Res., June 1, 2008; 14(11): 3283 - 3290. [Abstract] [Full Text] [PDF]

				Y. Suehiro, T. Okada, T. Okada, K. Anno, N. Okayama, K. Ueno, M. Hiura, M. Nakamura, T. Kondo, A. Oga, et al. Aneuploidy Predicts Outcome in Patients with Endometrial Carcinoma and Is Related to Lack of CDH13 Hypermethylation Clin. Cancer Res., June 1, 2008; 14(11): 3354 - 3361. [Abstract] [Full Text] [PDF]

				S. Luxen, S. A. Belinsky, and U. G. Knaus Silencing of DUOX NADPH Oxidases by Promoter Hypermethylation in Lung Cancer Cancer Res., February 15, 2008; 68(4): 1037 - 1045. [Abstract] [Full Text] [PDF]

				M M Hagleitner, A Lankester, P Maraschio, M Hulten, J P Fryns, C Schuetz, G Gimelli, E G Davies, A Gennery, B H Belohradsky, et al. Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome) J. Med. Genet., February 1, 2008; 45(2): 93 - 99. [Abstract] [Full Text] [PDF]

				J. Davidsson, A. Andersson, K. Paulsson, M. Heidenblad, M. Isaksson, A. Borg, J. Heldrup, M. Behrendtz, I. Panagopoulos, T. Fioretos, et al. Tiling resolution array comparative genomic hybridization, expression and methylation analyses of dup(1q) in Burkitt lymphomas and pediatric high hyperdiploid acute lymphoblastic leukemias reveal clustered near-centromeric breakpoints and overexpression of genes in 1q22-32.3 Hum. Mol. Genet., September 15, 2007; 16(18): 2215 - 2225. [Abstract] [Full Text] [PDF]

				M.-S. Chang, H. Uozaki, J.-M. Chong, T. Ushiku, K. Sakuma, S. Ishikawa, R. Hino, R. R. Barua, Y. Iwasaki, K. Arai, et al. CpG Island M;ethylation Status in Gastric Carcinoma with and without Infection of Epstein-Barr Virus. Clin. Cancer Res., May 15, 2006; 12(10): 2995 - 3002. [Abstract] [Full Text] [PDF]

				D. Rodenhiser and M. Mann Epigenetics and human disease: translating basic biology into clinical applications Can. Med. Assoc. J., January 31, 2006; 174(3): 341 - 348. [Abstract] [Full Text] [PDF]

				D. J. Weisenberger, M. Campan, T. I. Long, M. Kim, C. Woods, E. Fiala, M. Ehrlich, and P. W. Laird Analysis of repetitive element DNA methylation by MethyLight Nucleic Acids Res., December 2, 2005; 33(21): 6823 - 6836. [Abstract] [Full Text] [PDF]

				M. W.Y. Chan, S. H. Wei, P. Wen, Z. Wang, D. E. Matei, J. C. Liu, S. Liyanarachchi, R. Brown, K. P. Nephew, P. S. Yan, et al. Hypermethylation of 18S and 28S Ribosomal DNAs Predicts Progression-Free Survival in Patients with Ovarian Cancer Clin. Cancer Res., October 15, 2005; 11(20): 7376 - 7383. [Abstract] [Full Text] [PDF]

				C. Mund, B. Hackanson, C. Stresemann, M. Lubbert, and F. Lyko Characterization of DNA Demethylation Effects Induced by 5-Aza-2'-Deoxycytidine in Patients with Myelodysplastic Syndrome Cancer Res., August 15, 2005; 65(16): 7086 - 7090. [Abstract] [Full Text] [PDF]

				C. Mund, V. Beier, P. Bewerunge, M. Dahms, F. Lyko, and J. D. Hoheisel Array-based analysis of genomic DNA methylation patterns of the tumour suppressor gene p16INK4A promoter in colon carcinoma cell lines Nucleic Acids Res., April 28, 2005; 33(8): e73 - e73. [Abstract] [Full Text] [PDF]